nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—Arteriospasm coronary—Fluorouracil—head and neck cancer	0.0962	0.11	CcSEcCtD
Phenylephrine—Ischaemia—Vinblastine—head and neck cancer	0.0583	0.0665	CcSEcCtD
Phenylephrine—Skin necrosis—Hydroxyurea—head and neck cancer	0.0555	0.0633	CcSEcCtD
Phenylephrine—Isoprenaline—MAPK1—head and neck cancer	0.0454	0.823	CrCbGaD
Phenylephrine—Extravasation—Vinblastine—head and neck cancer	0.0244	0.0278	CcSEcCtD
Phenylephrine—Lacrimation—Fluorouracil—head and neck cancer	0.0237	0.0271	CcSEcCtD
Phenylephrine—Photophobia—Vinblastine—head and neck cancer	0.02	0.0228	CcSEcCtD
Phenylephrine—Skin exfoliation—Hydroxyurea—head and neck cancer	0.0185	0.0211	CcSEcCtD
Phenylephrine—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.0174	0.0198	CcSEcCtD
Phenylephrine—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.0173	0.0197	CcSEcCtD
Phenylephrine—Stinging—Fluorouracil—head and neck cancer	0.0172	0.0197	CcSEcCtD
Phenylephrine—Lacrimation—Docetaxel—head and neck cancer	0.0171	0.0195	CcSEcCtD
Phenylephrine—Eye irritation—Fluorouracil—head and neck cancer	0.0164	0.0186	CcSEcCtD
Phenylephrine—Extravasation—Fluorouracil—head and neck cancer	0.016	0.0182	CcSEcCtD
Phenylephrine—Lacrimation increased—Fluorouracil—head and neck cancer	0.0152	0.0173	CcSEcCtD
Phenylephrine—Photophobia—Fluorouracil—head and neck cancer	0.0131	0.0149	CcSEcCtD
Phenylephrine—Myocardial ischaemia—Docetaxel—head and neck cancer	0.0125	0.0143	CcSEcCtD
Phenylephrine—Eye irritation—Docetaxel—head and neck cancer	0.0118	0.0135	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Vinblastine—head and neck cancer	0.0117	0.0134	CcSEcCtD
Phenylephrine—Myocardial infarction—Vinblastine—head and neck cancer	0.0117	0.0133	CcSEcCtD
Phenylephrine—Extravasation—Docetaxel—head and neck cancer	0.0116	0.0132	CcSEcCtD
Phenylephrine—Lacrimation increased—Docetaxel—head and neck cancer	0.0109	0.0125	CcSEcCtD
Phenylephrine—Blood pressure increased—Docetaxel—head and neck cancer	0.0101	0.0115	CcSEcCtD
Phenylephrine—Isoprenaline—CYP1A1—head and neck cancer	0.00976	0.177	CrCbGaD
Phenylephrine—Skin exfoliation—Docetaxel—head and neck cancer	0.00962	0.011	CcSEcCtD
Phenylephrine—Pulmonary oedema—Docetaxel—head and neck cancer	0.00897	0.0102	CcSEcCtD
Phenylephrine—Angiopathy—Hydroxyurea—head and neck cancer	0.00884	0.0101	CcSEcCtD
Phenylephrine—Hypertension—Vinblastine—head and neck cancer	0.00803	0.00915	CcSEcCtD
Phenylephrine—Visual disturbance—Docetaxel—head and neck cancer	0.00772	0.0088	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.0077	0.00878	CcSEcCtD
Phenylephrine—Myocardial infarction—Fluorouracil—head and neck cancer	0.00766	0.00873	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00717	0.00818	CcSEcCtD
Phenylephrine—Paraesthesia—Vinblastine—head and neck cancer	0.00681	0.00777	CcSEcCtD
Phenylephrine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00679	0.00774	CcSEcCtD
Phenylephrine—Skin disorder—Hydroxyurea—head and neck cancer	0.00672	0.00767	CcSEcCtD
Phenylephrine—Abdominal pain upper—Docetaxel—head and neck cancer	0.00668	0.00762	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00668	0.00762	CcSEcCtD
Phenylephrine—Pain—Vinblastine—head and neck cancer	0.00649	0.0074	CcSEcCtD
Phenylephrine—Arrhythmia—Fluorouracil—head and neck cancer	0.00626	0.00714	CcSEcCtD
Phenylephrine—Dyspnoea—Hydroxyurea—head and neck cancer	0.00617	0.00704	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00598	0.00681	CcSEcCtD
Phenylephrine—Pain—Hydroxyurea—head and neck cancer	0.00592	0.00675	CcSEcCtD
Phenylephrine—Vision blurred—Fluorouracil—head and neck cancer	0.00575	0.00656	CcSEcCtD
Phenylephrine—Hypersensitivity—Vinblastine—head and neck cancer	0.00559	0.00638	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00556	0.00634	CcSEcCtD
Phenylephrine—Myocardial infarction—Docetaxel—head and neck cancer	0.00553	0.0063	CcSEcCtD
Phenylephrine—Chest pain—Fluorouracil—head and neck cancer	0.0052	0.00593	CcSEcCtD
Phenylephrine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.0051	0.00581	CcSEcCtD
Phenylephrine—Dizziness—Vinblastine—head and neck cancer	0.00502	0.00572	CcSEcCtD
Phenylephrine—CYP1A2—Arylamine metabolism—NAT2—head and neck cancer	0.005	0.0738	CbGpPWpGaD
Phenylephrine—Nervous system disorder—Fluorouracil—head and neck cancer	0.00489	0.00557	CcSEcCtD
Phenylephrine—Visual impairment—Docetaxel—head and neck cancer	0.00488	0.00556	CcSEcCtD
Phenylephrine—Tachycardia—Fluorouracil—head and neck cancer	0.00486	0.00554	CcSEcCtD
Phenylephrine—Vomiting—Vinblastine—head and neck cancer	0.00483	0.0055	CcSEcCtD
Phenylephrine—Headache—Vinblastine—head and neck cancer	0.00475	0.00542	CcSEcCtD
Phenylephrine—Cardiac disorder—Docetaxel—head and neck cancer	0.0047	0.00536	CcSEcCtD
Phenylephrine—Angiopathy—Docetaxel—head and neck cancer	0.00459	0.00524	CcSEcCtD
Phenylephrine—Dizziness—Hydroxyurea—head and neck cancer	0.00458	0.00522	CcSEcCtD
Phenylephrine—Immune system disorder—Docetaxel—head and neck cancer	0.00457	0.00521	CcSEcCtD
Phenylephrine—Mediastinal disorder—Docetaxel—head and neck cancer	0.00456	0.0052	CcSEcCtD
Phenylephrine—Arrhythmia—Docetaxel—head and neck cancer	0.00452	0.00516	CcSEcCtD
Phenylephrine—Nausea—Vinblastine—head and neck cancer	0.00451	0.00514	CcSEcCtD
Phenylephrine—Paraesthesia—Fluorouracil—head and neck cancer	0.00447	0.0051	CcSEcCtD
Phenylephrine—Dyspnoea—Fluorouracil—head and neck cancer	0.00444	0.00506	CcSEcCtD
Phenylephrine—Mental disorder—Docetaxel—head and neck cancer	0.00443	0.00506	CcSEcCtD
Phenylephrine—Vomiting—Hydroxyurea—head and neck cancer	0.0044	0.00502	CcSEcCtD
Phenylephrine—Rash—Hydroxyurea—head and neck cancer	0.00436	0.00498	CcSEcCtD
Phenylephrine—Dermatitis—Hydroxyurea—head and neck cancer	0.00436	0.00497	CcSEcCtD
Phenylephrine—Headache—Hydroxyurea—head and neck cancer	0.00434	0.00494	CcSEcCtD
Phenylephrine—Dysgeusia—Docetaxel—head and neck cancer	0.00431	0.00492	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.0043	0.0049	CcSEcCtD
Phenylephrine—Pain—Fluorouracil—head and neck cancer	0.00426	0.00486	CcSEcCtD
Phenylephrine—Nausea—Hydroxyurea—head and neck cancer	0.00411	0.00469	CcSEcCtD
Phenylephrine—Urticaria—Fluorouracil—head and neck cancer	0.00396	0.00451	CcSEcCtD
Phenylephrine—Syncope—Docetaxel—head and neck cancer	0.00395	0.0045	CcSEcCtD
Phenylephrine—Palpitations—Docetaxel—head and neck cancer	0.00389	0.00444	CcSEcCtD
Phenylephrine—Loss of consciousness—Docetaxel—head and neck cancer	0.00387	0.00442	CcSEcCtD
Phenylephrine—Hypertension—Docetaxel—head and neck cancer	0.0038	0.00434	CcSEcCtD
Phenylephrine—Chest pain—Docetaxel—head and neck cancer	0.00375	0.00428	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00373	0.00425	CcSEcCtD
Phenylephrine—Hypersensitivity—Fluorouracil—head and neck cancer	0.00367	0.00419	CcSEcCtD
Phenylephrine—Shock—Docetaxel—head and neck cancer	0.00354	0.00403	CcSEcCtD
Phenylephrine—Nervous system disorder—Docetaxel—head and neck cancer	0.00353	0.00402	CcSEcCtD
Phenylephrine—Pruritus—Fluorouracil—head and neck cancer	0.00352	0.00402	CcSEcCtD
Phenylephrine—Tachycardia—Docetaxel—head and neck cancer	0.00351	0.004	CcSEcCtD
Phenylephrine—Skin disorder—Docetaxel—head and neck cancer	0.00349	0.00398	CcSEcCtD
Phenylephrine—Dizziness—Fluorouracil—head and neck cancer	0.00329	0.00376	CcSEcCtD
Phenylephrine—Paraesthesia—Docetaxel—head and neck cancer	0.00323	0.00368	CcSEcCtD
Phenylephrine—Dyspnoea—Docetaxel—head and neck cancer	0.00321	0.00366	CcSEcCtD
Phenylephrine—Vomiting—Fluorouracil—head and neck cancer	0.00317	0.00361	CcSEcCtD
Phenylephrine—Rash—Fluorouracil—head and neck cancer	0.00314	0.00358	CcSEcCtD
Phenylephrine—Dermatitis—Fluorouracil—head and neck cancer	0.00314	0.00358	CcSEcCtD
Phenylephrine—Headache—Fluorouracil—head and neck cancer	0.00312	0.00356	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.0031	0.00354	CcSEcCtD
Phenylephrine—Pain—Docetaxel—head and neck cancer	0.00307	0.00351	CcSEcCtD
Phenylephrine—Nausea—Fluorouracil—head and neck cancer	0.00296	0.00337	CcSEcCtD
Phenylephrine—Hypersensitivity—Docetaxel—head and neck cancer	0.00265	0.00302	CcSEcCtD
Phenylephrine—Pruritus—Docetaxel—head and neck cancer	0.00254	0.0029	CcSEcCtD
Phenylephrine—Dizziness—Docetaxel—head and neck cancer	0.00238	0.00271	CcSEcCtD
Phenylephrine—Vomiting—Docetaxel—head and neck cancer	0.00229	0.00261	CcSEcCtD
Phenylephrine—Rash—Docetaxel—head and neck cancer	0.00227	0.00259	CcSEcCtD
Phenylephrine—Dermatitis—Docetaxel—head and neck cancer	0.00227	0.00258	CcSEcCtD
Phenylephrine—Headache—Docetaxel—head and neck cancer	0.00225	0.00257	CcSEcCtD
Phenylephrine—CYP1A2—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00218	0.0322	CbGpPWpGaD
Phenylephrine—Nausea—Docetaxel—head and neck cancer	0.00214	0.00244	CcSEcCtD
Phenylephrine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00186	0.0274	CbGpPWpGaD
Phenylephrine—MAOA—Oxidative Stress—SOD2—head and neck cancer	0.00186	0.0274	CbGpPWpGaD
Phenylephrine—MAOA—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.0018	0.0266	CbGpPWpGaD
Phenylephrine—MAOA—Oxidative Stress—GPX1—head and neck cancer	0.00177	0.0261	CbGpPWpGaD
Phenylephrine—MAOA—Oxidative Stress—CYP1A1—head and neck cancer	0.00175	0.0258	CbGpPWpGaD
Phenylephrine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00169	0.025	CbGpPWpGaD
Phenylephrine—ADRA1B—AMPK Signaling—CCNA1—head and neck cancer	0.00161	0.0238	CbGpPWpGaD
Phenylephrine—ADRA1A—AMPK Signaling—CCNA1—head and neck cancer	0.00143	0.0211	CbGpPWpGaD
Phenylephrine—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.00126	0.0186	CbGpPWpGaD
Phenylephrine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00114	0.0168	CbGpPWpGaD
Phenylephrine—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00107	0.0158	CbGpPWpGaD
Phenylephrine—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.00103	0.0151	CbGpPWpGaD
Phenylephrine—ADRA1D—G alpha (q) signalling events—KISS1—head and neck cancer	0.000993	0.0146	CbGpPWpGaD
Phenylephrine—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.000973	0.0143	CbGpPWpGaD
Phenylephrine—MAOA—Biological oxidations—NAT2—head and neck cancer	0.000926	0.0137	CbGpPWpGaD
Phenylephrine—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.000894	0.0132	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1—head and neck cancer	0.000888	0.0131	CbGpPWpGaD
Phenylephrine—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00086	0.0127	CbGpPWpGaD
Phenylephrine—ADRA1B—G alpha (q) signalling events—KISS1—head and neck cancer	0.000824	0.0122	CbGpPWpGaD
Phenylephrine—ADRA1D—G alpha (q) signalling events—GRP—head and neck cancer	0.000818	0.0121	CbGpPWpGaD
Phenylephrine—MAOA—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000816	0.012	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1—head and neck cancer	0.000737	0.0109	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—KISS1—head and neck cancer	0.000732	0.0108	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—head and neck cancer	0.000732	0.0108	CbGpPWpGaD
Phenylephrine—ADRA1B—G alpha (q) signalling events—GRP—head and neck cancer	0.000679	0.01	CbGpPWpGaD
Phenylephrine—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000664	0.00979	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.000658	0.0097	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1—head and neck cancer	0.000655	0.00966	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—head and neck cancer	0.000607	0.00895	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—GRP—head and neck cancer	0.000603	0.00889	CbGpPWpGaD
Phenylephrine—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000585	0.00863	CbGpPWpGaD
Phenylephrine—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000584	0.00861	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.000546	0.00805	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.000542	0.00799	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—head and neck cancer	0.000539	0.00795	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—KISS1—head and neck cancer	0.000501	0.00739	CbGpPWpGaD
Phenylephrine—ADRA1A—Endothelin Pathways—MAPK1—head and neck cancer	0.000492	0.00726	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.000485	0.00715	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000459	0.00677	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000459	0.00677	CbGpPWpGaD
Phenylephrine—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000459	0.00677	CbGpPWpGaD
Phenylephrine—MAOA—Biological oxidations—GSTM1—head and neck cancer	0.000457	0.00674	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.00045	0.00663	CbGpPWpGaD
Phenylephrine—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000434	0.0064	CbGpPWpGaD
Phenylephrine—MAOA—Biological oxidations—CYP1A1—head and neck cancer	0.000433	0.00639	CbGpPWpGaD
Phenylephrine—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00043	0.00633	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—KISS1—head and neck cancer	0.000416	0.00613	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—GRP—head and neck cancer	0.000413	0.00608	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.000399	0.00589	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—UROD—head and neck cancer	0.000381	0.00562	CbGpPWpGaD
Phenylephrine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000371	0.00547	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—KISS1—head and neck cancer	0.000369	0.00545	CbGpPWpGaD
Phenylephrine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000366	0.0054	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—GRP—head and neck cancer	0.000342	0.00505	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000341	0.00503	CbGpPWpGaD
Phenylephrine—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000337	0.00497	CbGpPWpGaD
Phenylephrine—ADRA1B—LPA receptor mediated events—EGFR—head and neck cancer	0.000326	0.00481	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—GRP—head and neck cancer	0.000304	0.00448	CbGpPWpGaD
Phenylephrine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000301	0.00444	CbGpPWpGaD
Phenylephrine—ADRA1D—G alpha (12/13) signalling events—PIK3CA—head and neck cancer	0.000301	0.00443	CbGpPWpGaD
Phenylephrine—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	0.000288	0.00425	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—KISS1—head and neck cancer	0.000283	0.00417	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000273	0.00403	CbGpPWpGaD
Phenylephrine—ADRA1B—AMPK Signaling—PIK3CA—head and neck cancer	0.000267	0.00393	CbGpPWpGaD
Phenylephrine—ADRA1B—LPA receptor mediated events—HRAS—head and neck cancer	0.000262	0.00386	CbGpPWpGaD
Phenylephrine—ADRA1B—AMPK Signaling—TP53—head and neck cancer	0.000258	0.0038	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—KISS1—head and neck cancer	0.000257	0.00379	CbGpPWpGaD
Phenylephrine—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000255	0.00377	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000253	0.00373	CbGpPWpGaD
Phenylephrine—ADRA1B—G alpha (12/13) signalling events—PIK3CA—head and neck cancer	0.000249	0.00368	CbGpPWpGaD
Phenylephrine—ADRA1A—AMPK Signaling—PIK3CA—head and neck cancer	0.000237	0.00349	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—KISS1—head and neck cancer	0.000235	0.00346	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—GRP—head and neck cancer	0.000233	0.00344	CbGpPWpGaD
Phenylephrine—ADRA1B—LPA receptor mediated events—AKT1—head and neck cancer	0.000231	0.00341	CbGpPWpGaD
Phenylephrine—ADRA1A—AMPK Signaling—TP53—head and neck cancer	0.000229	0.00338	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (12/13) signalling events—PIK3CA—head and neck cancer	0.000222	0.00327	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.00022	0.00324	CbGpPWpGaD
Phenylephrine—ADRA1B—AMPK Signaling—AKT1—head and neck cancer	0.000218	0.00321	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000215	0.00317	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—KISS1—head and neck cancer	0.000213	0.00315	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—GRP—head and neck cancer	0.000212	0.00312	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—KISS1—head and neck cancer	0.000209	0.00308	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000194	0.00285	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000194	0.00285	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000194	0.00285	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—GRP—head and neck cancer	0.000193	0.00285	CbGpPWpGaD
Phenylephrine—ADRA1A—AMPK Signaling—AKT1—head and neck cancer	0.000193	0.00285	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—KISS1—head and neck cancer	0.00019	0.00279	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—GRP—head and neck cancer	0.000176	0.00259	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—GRP—head and neck cancer	0.000172	0.00253	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	0.000169	0.00249	CbGpPWpGaD
Phenylephrine—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	0.000166	0.00245	CbGpPWpGaD
Phenylephrine—MAOA—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000162	0.00239	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	0.00016	0.00236	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—NAT2—head and neck cancer	0.000158	0.00233	CbGpPWpGaD
Phenylephrine—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000158	0.00232	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000157	0.00231	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—GRP—head and neck cancer	0.000156	0.0023	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000155	0.00229	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—KISS1—head and neck cancer	0.000152	0.00224	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000149	0.0022	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000149	0.0022	CbGpPWpGaD
Phenylephrine—ADRA1D—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000145	0.00213	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—UROD—head and neck cancer	0.000141	0.00207	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—DPYD—head and neck cancer	0.000139	0.00205	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—YAP1—head and neck cancer	0.000132	0.00194	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.00013	0.00192	CbGpPWpGaD
Phenylephrine—MAOA—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.00013	0.00192	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.000129	0.00191	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—KISS1—head and neck cancer	0.000126	0.00186	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—GRP—head and neck cancer	0.000125	0.00184	CbGpPWpGaD
Phenylephrine—MAOA—Neuronal System—MAPK1—head and neck cancer	0.000124	0.00183	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000124	0.00183	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000124	0.00182	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—STAT6—head and neck cancer	0.000121	0.00179	CbGpPWpGaD
Phenylephrine—ADRA1B—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.00012	0.00177	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.00012	0.00177	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000116	0.0017	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—KISS1—head and neck cancer	0.000112	0.00165	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.00011	0.00162	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.00011	0.00162	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000109	0.00161	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—YAP1—head and neck cancer	0.000107	0.00158	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.000107	0.00158	CbGpPWpGaD
Phenylephrine—ADRA1A—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000107	0.00157	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GRP—head and neck cancer	0.000104	0.00153	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—STAT6—head and neck cancer	0.000101	0.00149	CbGpPWpGaD
Phenylephrine—MAOA—Neuronal System—HRAS—head and neck cancer	9.97e-05	0.00147	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	9.94e-05	0.00147	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	9.54e-05	0.00141	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GRP—head and neck cancer	9.22e-05	0.00136	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—STAT6—head and neck cancer	8.95e-05	0.00132	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—YAP1—head and neck cancer	8.92e-05	0.00131	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	8.83e-05	0.0013	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—YAP1—head and neck cancer	7.92e-05	0.00117	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—TYMS—head and neck cancer	7.91e-05	0.00117	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GSTM1—head and neck cancer	7.82e-05	0.00115	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—GPX1—head and neck cancer	7.49e-05	0.0011	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—CYP1A1—head and neck cancer	7.41e-05	0.00109	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—IL2—head and neck cancer	6.21e-05	0.000916	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.2e-05	0.000914	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.14e-05	0.000905	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—NAT2—head and neck cancer	5.84e-05	0.000861	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—IL2—head and neck cancer	5.64e-05	0.000832	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—IL2—head and neck cancer	5.16e-05	0.00076	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—DPYD—head and neck cancer	5.12e-05	0.000755	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—YAP1—head and neck cancer	4.86e-05	0.000716	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—NOTCH1—head and neck cancer	4.84e-05	0.000714	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL2—head and neck cancer	4.68e-05	0.00069	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—IL2—head and neck cancer	4.58e-05	0.000675	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—MAPK3—head and neck cancer	4.54e-05	0.000669	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PTGS2—head and neck cancer	4.41e-05	0.00065	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—MAPK1—head and neck cancer	4.32e-05	0.000636	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—EGFR—head and neck cancer	4.31e-05	0.000636	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL2—head and neck cancer	4.16e-05	0.000613	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—PIK3CA—head and neck cancer	4.12e-05	0.000608	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—NOTCH1—head and neck cancer	4.02e-05	0.000593	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PTEN—head and neck cancer	3.84e-05	0.000567	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—MAPK3—head and neck cancer	3.76e-05	0.000555	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—PIK3CA—head and neck cancer	3.74e-05	0.000552	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.65e-05	0.000538	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—MAPK1—head and neck cancer	3.58e-05	0.000528	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—EGFR—head and neck cancer	3.58e-05	0.000528	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—NOTCH1—head and neck cancer	3.57e-05	0.000526	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—HRAS—head and neck cancer	3.46e-05	0.000511	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PIK3CA—head and neck cancer	3.42e-05	0.000505	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—AKT1—head and neck cancer	3.37e-05	0.000497	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—MAPK3—head and neck cancer	3.34e-05	0.000493	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL2—head and neck cancer	3.33e-05	0.000491	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CCND1—head and neck cancer	3.25e-05	0.000479	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.18e-05	0.000469	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—MAPK1—head and neck cancer	3.18e-05	0.000469	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—EGFR—head and neck cancer	3.18e-05	0.000469	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PTEN—head and neck cancer	3.14e-05	0.000462	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PIK3CA—head and neck cancer	3.11e-05	0.000458	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—AKT1—head and neck cancer	3.06e-05	0.000451	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PIK3CA—head and neck cancer	3.04e-05	0.000448	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—TYMS—head and neck cancer	2.92e-05	0.00043	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GSTM1—head and neck cancer	2.88e-05	0.000425	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—HRAS—head and neck cancer	2.88e-05	0.000424	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—VEGFA—head and neck cancer	2.83e-05	0.000418	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—STAT3—head and neck cancer	2.8e-05	0.000413	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—AKT1—head and neck cancer	2.8e-05	0.000412	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL2—head and neck cancer	2.77e-05	0.000408	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GPX1—head and neck cancer	2.76e-05	0.000407	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PIK3CA—head and neck cancer	2.76e-05	0.000407	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	2.73e-05	0.000403	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—PIK3CA—head and neck cancer	2.71e-05	0.0004	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCND1—head and neck cancer	2.7e-05	0.000398	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAPK3—head and neck cancer	2.68e-05	0.000395	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PTEN—head and neck cancer	2.6e-05	0.000384	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—HRAS—head and neck cancer	2.55e-05	0.000377	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAPK1—head and neck cancer	2.55e-05	0.000376	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—EGFR—head and neck cancer	2.55e-05	0.000376	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—AKT1—head and neck cancer	2.54e-05	0.000374	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—AKT1—head and neck cancer	2.48e-05	0.000366	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL2—head and neck cancer	2.46e-05	0.000362	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCND1—head and neck cancer	2.4e-05	0.000353	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—VEGFA—head and neck cancer	2.35e-05	0.000347	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—STAT3—head and neck cancer	2.33e-05	0.000343	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PTEN—head and neck cancer	2.31e-05	0.000341	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—AKT1—head and neck cancer	2.26e-05	0.000333	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.25e-05	0.000331	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAPK3—head and neck cancer	2.22e-05	0.000328	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—AKT1—head and neck cancer	2.22e-05	0.000327	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PIK3CA—head and neck cancer	2.21e-05	0.000326	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TP53—head and neck cancer	2.14e-05	0.000316	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAPK1—head and neck cancer	2.12e-05	0.000312	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—EGFR—head and neck cancer	2.12e-05	0.000312	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—VEGFA—head and neck cancer	2.09e-05	0.000308	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—STAT3—head and neck cancer	2.07e-05	0.000305	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—HRAS—head and neck cancer	2.05e-05	0.000302	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAPK3—head and neck cancer	1.98e-05	0.000291	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAPK1—head and neck cancer	1.88e-05	0.000277	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—EGFR—head and neck cancer	1.88e-05	0.000277	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PIK3CA—head and neck cancer	1.84e-05	0.000271	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—AKT1—head and neck cancer	1.81e-05	0.000266	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TP53—head and neck cancer	1.78e-05	0.000262	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—HRAS—head and neck cancer	1.7e-05	0.00025	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PIK3CA—head and neck cancer	1.63e-05	0.00024	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.63e-05	0.00024	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TP53—head and neck cancer	1.58e-05	0.000233	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—HRAS—head and neck cancer	1.51e-05	0.000222	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—AKT1—head and neck cancer	1.5e-05	0.000221	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PTEN—head and neck cancer	1.42e-05	0.000209	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—AKT1—head and neck cancer	1.33e-05	0.000196	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1e-05	0.000147	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—AKT1—head and neck cancer	8.17e-06	0.00012	CbGpPWpGaD
